164 related articles for article (PubMed ID: 9403341)
1. Inhibition of contact hypersensitivity with different analogs of benzoporphyrin derivative.
Simkin GO; King DE; Levy JG; Chan AH; Hunt DW
Immunopharmacology; 1997 Oct; 37(2-3):221-30. PubMed ID: 9403341
[TBL] [Abstract][Full Text] [Related]
2. IL-10 contributes to the inhibition of contact hypersensitivity in mice treated with photodynamic therapy.
Simkin GO; Tao JS; Levy JG; Hunt DW
J Immunol; 2000 Mar; 164(5):2457-62. PubMed ID: 10679082
[TBL] [Abstract][Full Text] [Related]
3. Singlet oxygen producing photosensitizers in photophoresis.
van Iperen HP; Beijersbergen van Henegouwen GM
J Photochem Photobiol B; 1997 Apr; 38(2-3):203-8. PubMed ID: 9203382
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic alteration of the surface receptor expression pattern of murine splenic dendritic cells.
King DE; Jiang H; Simkin GO; Obochi MO; Levy JG; Hunt DW
Scand J Immunol; 1999 Feb; 49(2):184-92. PubMed ID: 10075023
[TBL] [Abstract][Full Text] [Related]
5. Benzophenothiazine and benzoporphyrin derivative combination phototherapy effectively eradicates large murine sarcomas.
Cincotta L; Szeto D; Lampros E; Hasan T; Cincotta AH
Photochem Photobiol; 1996 Feb; 63(2):229-37. PubMed ID: 8657737
[TBL] [Abstract][Full Text] [Related]
6. Defining the therapeutic window of vertebral photodynamic therapy in a murine pre-clinical model of breast cancer metastasis using the photosensitizer BPD-MA (Verteporfin).
Akens MK; Hardisty MR; Wilson BC; Schwock J; Whyne CM; Burch S; Yee AJ
Breast Cancer Res Treat; 2010 Jan; 119(2):325-33. PubMed ID: 19263216
[TBL] [Abstract][Full Text] [Related]
7. Calculation of singlet oxygen dose using explicit and implicit dose metrics during benzoporphyrin derivative monoacid ring A (BPD-MA)-PDT in vitro and correlation with MLL cell survival.
Weston MA; Patterson MS
Photochem Photobiol; 2011; 87(5):1129-37. PubMed ID: 21575000
[TBL] [Abstract][Full Text] [Related]
8. Induction of suppressor T cells and inhibition of contact hypersensitivity in mice by 12-O-tetradecanoylphorbol-13-acetate and its analogs.
Kodari E; Pavone A; Reiners JJ
J Invest Dermatol; 1991 Jun; 96(6):864-70. PubMed ID: 1828476
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of singlet oxygen explicit dosimetry for predicting treatment outcomes of benzoporphyrin derivative monoacid ring A-mediated photodynamic therapy.
Kim MM; Penjweini R; Zhu TC
J Biomed Opt; 2017 Feb; 22(2):28002. PubMed ID: 28301655
[TBL] [Abstract][Full Text] [Related]
10. Verteporfin mediated sequence dependent combination therapy against ovarian cancer cell line.
Erdem SS; Obeidin VA; Yigitbasi T; Tumer SS; Yigit P
J Photochem Photobiol B; 2018 Jun; 183():266-274. PubMed ID: 29747146
[TBL] [Abstract][Full Text] [Related]
11. Dextran-Benzoporphyrin Derivative (BPD) Coated Superparamagnetic Iron Oxide Nanoparticle (SPION) Micelles for T
Yan L; Luo L; Amirshaghaghi A; Miller J; Meng C; You T; Busch TM; Tsourkas A; Cheng Z
Bioconjug Chem; 2019 Nov; 30(11):2974-2981. PubMed ID: 31661959
[TBL] [Abstract][Full Text] [Related]
12. Selective depletion of a thymocyte subset in vitro with an immunomodulatory photosensitizer.
Jiang H; Granville DJ; McManus BM; Levy JG; Hunt DW
Clin Immunol; 1999 May; 91(2):178-87. PubMed ID: 10227810
[TBL] [Abstract][Full Text] [Related]
13. Benzoporphyrin derivative monacid ring A (Verteporfin) alone has no inhibitory effect on intimal hyperplasia: in vitro and in vivo results.
Turnbull RG; Chen JC; Labow RS; Margaron P; Hsiang YN
J Invest Surg; 2000; 13(3):153-9. PubMed ID: 10933111
[TBL] [Abstract][Full Text] [Related]
14. Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD).
Fingar VH; Kik PK; Haydon PS; Cerrito PB; Tseng M; Abang E; Wieman TJ
Br J Cancer; 1999 Apr; 79(11-12):1702-8. PubMed ID: 10206280
[TBL] [Abstract][Full Text] [Related]
15. Application of long-circulating liposomes to cancer photodynamic therapy.
Oku N; Saito N; Namba Y; Tsukada H; Dolphin D; Okada S
Biol Pharm Bull; 1997 Jun; 20(6):670-3. PubMed ID: 9212988
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy targeted to tumor-induced angiogenic vessels.
Kurohane K; Tominaga A; Sato K; North JR; Namba Y; Oku N
Cancer Lett; 2001 Jun; 167(1):49-56. PubMed ID: 11323098
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic modulation of wound healing with BPD-MA and CASP.
Parekh SG; Trauner KB; Zarins B; Foster TE; Anderson RR
Lasers Surg Med; 1999; 24(5):375-81. PubMed ID: 10406478
[TBL] [Abstract][Full Text] [Related]
18. Consequences of the photodynamic treatment of resting and activated peripheral T lymphocytes.
Hunt DW; Jiang H; Granville DJ; Chan AH; Leong S; Levy JG
Immunopharmacology; 1999 Jan; 41(1):31-44. PubMed ID: 9950267
[TBL] [Abstract][Full Text] [Related]
19. Antiangiogenic photodynamic therapy (PDT) using Visudyne causes effective suppression of tumor growth.
Ichikawa K; Takeuchi Y; Yonezawa S; Hikita T; Kurohane K; Namba Y; Oku N
Cancer Lett; 2004 Mar; 205(1):39-48. PubMed ID: 15036659
[TBL] [Abstract][Full Text] [Related]
20. Local- and systemic-mediated suppression of contact hypersensitivity in mice by several structurally unrelated classes of tumor promoters.
Kodari E; Pavone A; Reiners JJ
Carcinogenesis; 1991 Oct; 12(10):1933-7. PubMed ID: 1934273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
